Elena Shklovskaya

Missenden Road
Camperdown, NSW 2050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma.

Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma.

Journal: Oncoimmunology

Published: March 11, 2026

Correction: T cell-derived small extracellular vesicles in cancer-immune interactions.

Correction: T cell-derived small extracellular vesicles in cancer-immune interactions.

Journal: Cancer immunology, immunotherapy : CII

Published: October 15, 2025

Distinctive features of the tumor and immune microenvironment in glioblastoma.

Distinctive features of the tumor and immune microenvironment in glioblastoma.

Journal: NPJ precision oncology

Published: August 12, 2025

T cell-derived small extracellular vesicles in cancer-immune interactions.

T cell-derived small extracellular vesicles in cancer-immune interactions.

Journal: Cancer immunology, immunotherapy : CII

Published: April 15, 2025

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Journal: Nature medicine

Published: July 24, 2024

MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4+ T cells in vivo.

MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4+ T cells in vivo.

Journal: Oncoimmunology

Published: December 21, 2023

Diagnosis of breast implant associated anaplastic large cell lymphoma by analysis of cytokines in peri-implant seromas.

Diagnosis of breast implant associated anaplastic large cell lymphoma by analysis of cytokines in peri-implant seromas.

Journal: American journal of hematology

Published: January 18, 2023

Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.

Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 10, 2022

IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.

IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.

Journal: The Journal of investigative dermatology

Published: October 02, 2022

Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers.

Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers.

Journal: Cancers

Published: August 17, 2022

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.

Journal: Nature communications

Published: June 25, 2022

MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.

MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.

Journal: International journal of molecular sciences

Published: May 22, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026